11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The Relationship of Clinicopathological Factors of the Tumor with Preoperative TSH Level in Papillary Thyroid Cancers

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          Thyroid-stimulating hormone/thyrotropin (TSH) is known to induce malignancies and tissue growth of the thyroid gland. While the relationship of higher levels of TSH with advanced stages of cancer had been published in previous studies, the relationship of the tumor with the clinicopathological factors had not been completely evaluated. The aim of the present study was to evaluate the relationship between highly risky clinicopathological factors with preoperative high levels of TSH.

          Materials and Methods

          The records of 89 patients (67 females and 22 males) who underwent surgery for differentiated thyroid cancer between 2011 and 2013 were reviewed. The relationship of preoperative TSH between tumor size, multicentricity, lymphovascular invasion, extrathyroidal extension, central neck metastasis, and lateral neck metastasis was evaluated.

          Results

          The preoperative TSH levels were high in patients with multicentricity (p=0.022), lymphovascular invasion (p=0.018), and central neck metastasis (p=0.002). The prevalence of extrathyroidal extension (p=0.41), lymphovascular invasion (p=0.020), and central metastasis (p=0.009) was significantly high in patients with a TSH level ≥2.5 mIU/L. The preoperative TSH levels were determined as an independent predictive risk factor for central neck metastases (p=0.012) and extrathyroidal extension (p=0.041) in multinomial logistical regression analysis.

          Conclusion

          The power of radiological imaging for the identification of central neck metastases in preoperative evaluation is limited. The preoperative high level of TSH is an independent predictive factor for central metastases and extrathyroidal extension. It can help to predict tumor staging. Furthermore, related with multicentricity and lymphovascular invasion, it can affect the high risk characteristics of the tumor except the stage. The preoperative TSH level can be considered for the probability of preoperative metastases and can contribute to plan the extent of surgery.

          Related collections

          Author and article information

          Journal
          Eurasian J Med
          Eurasian J Med
          The Eurasian Journal of Medicine
          The Eurasian Journal of Medicine
          1308-8734
          1308-8742
          February 2019
          03 December 2018
          : 51
          : 1
          : 8-11
          Affiliations
          [1 ]Department of General Surgery, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey
          [2 ]Department of Pathology, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey
          Author notes
          Correspondence to: Evren Besler, E-mail: evrenbesler@ 123456hotmail.com
          Author information
          http://orcid.org/0000-0002-3065-3585
          http://orcid.org/0000-0001-9759-8798
          http://orcid.org/0000-0002-7353-8245
          http://orcid.org/0000-0001-9353-8261
          http://orcid.org/0000-0002-3540-4772
          http://orcid.org/000-0002-4829-4728
          http://orcid.org/0000-0003-3714-5169
          http://orcid.org/0000-0003-1826-1615
          Article
          PMC6422630 PMC6422630 6422630 eajm-51-1-8
          10.5152/eurasianjmed.2018.17381
          6422630
          30911248
          a68dd4b7-ef9b-4d31-a4e2-13aa70563673
          ©Copyright 2019 by the Atatürk University School of Medicine - Available online at www.eurasianjmed.com
          History
          : 05 December 2017
          : 16 March 2018
          Categories
          Original Article

          thyrotropin/thyroid-stimulating hormone,Clinicopathological factors,thyroid cancer

          Comments

          Comment on this article